MAPT and tauopathy: HSP70 and HSP90s are involved in tau stability by inhibiting tau degradation, which leads to hyperphosphorylation of tau [28,39] and the inhibitors of HSP70 and HSP90 attenuate tauopathy and degrade abnormal tau [40,41].